BeOne Medicines Ltd. - American Depositary Shares (NQ:ONC)

312.69 +0.96 (+0.31%)

Streaming Delayed Price Updated: 12:53 PM EST, Dec 26, 2025 Add to My Watchlist

Price and Volume

Volume	44,721
Open	311.24
Bid (Size)	312.30 (40)
Ask (Size)	313.09 (40)
Prev. Close	311.73
Today's Range	310.29 - 313.23
52wk Range	172.67 - 385.22
Shares Outstanding	1,211,067,023
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 23, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

December 18, 2025

From BeOne Medicines Ltd.

Via Business Wire

Performance

YTD	+69.9%	+69.9%
1 Month	-6.7%	-6.7%
3 Month	-4.9%	-4.9%
6 Month	+22.9%	+22.9%
1 Year	+69.9%	+69.9%

More News

BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

December 08, 2025

From BeOne Medicines Ltd.

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Where BeOne Medicines Stands With Analysts ↗

October 08, 2025

Via Benzinga

BeOne Medicines Announced Sonrotoclax In Combination With BRUKINSA Demonstrated Rapid MRD Negativity In Treatment-naive CLL, Regardless Of High-risk Features ↗

December 07, 2025

Via Benzinga

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

December 07, 2025

From BeOne Medicines Ltd.

Via Business Wire

Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗

November 26, 2025

Via Investor's Business Daily

Analyst Expectations For BeOne Medicines's Future ↗

September 18, 2025

Via Benzinga

U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

November 26, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025

November 20, 2025

From BeOne Medicines Ltd.

Via Business Wire

Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans ↗

November 17, 2025

Via Benzinga

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

November 17, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates

November 06, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines to Present at Upcoming Investor Conferences

October 28, 2025

From BeOne Medicines Ltd.

Via Business Wire

Investor Exits $5.5 Million Perpetua Resources Stake Amid Stock's 150% Rally ↗

October 27, 2025

Via The Motley Fool

BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 6

October 22, 2025

From BeOne Medicines Ltd.

Via Business Wire

What's Going On With Summit Therapeutics Stock On Monday? ↗

October 20, 2025

Via Benzinga

BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025

October 20, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA

October 13, 2025

From BeOne Medicines Ltd.

Via Business Wire

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order ↗

September 10, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio? ↗

September 07, 2025

Via Benzinga

Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

September 02, 2025

Via Benzinga

Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket ↗

September 02, 2025

Via Benzinga

Frequently Asked Questions

Is BeOne Medicines Ltd. - American Depositary Shares publicly traded?

Yes, BeOne Medicines Ltd. - American Depositary Shares is publicly traded.

What exchange does BeOne Medicines Ltd. - American Depositary Shares trade on?

BeOne Medicines Ltd. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for BeOne Medicines Ltd. - American Depositary Shares?

The ticker symbol for BeOne Medicines Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market

What is the current price of BeOne Medicines Ltd. - American Depositary Shares?

The current price of BeOne Medicines Ltd. - American Depositary Shares is 312.69

When was BeOne Medicines Ltd. - American Depositary Shares last traded?

The last trade of BeOne Medicines Ltd. - American Depositary Shares was at 12/26/25 12:53 PM ET

What is the market capitalization of BeOne Medicines Ltd. - American Depositary Shares?

The market capitalization of BeOne Medicines Ltd. - American Depositary Shares is 378.69B

How many shares of BeOne Medicines Ltd. - American Depositary Shares are outstanding?

BeOne Medicines Ltd. - American Depositary Shares has 379B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.